STOK (NASDAQ) - 30-Min Chart Trade Setup Breakdown ! 🚀
🔍 Stock: STOK (NASDAQ)
⏳ Timeframe: 30-Min Chart
📈 Setup Type: Bullish Breakout
📍 Trade Plan:
✅ Entry Zone: Above $12.60 - $12.70 (Breakout Confirmation)
🚀 Take Profit 1 (TP1): $13.32 (First Resistance)
🚀 Take Profit 2 (TP2): $14.21 (Extended Bullish Target)
🔻 Stop-Loss (SL): Below $11.94 (Key S
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.68 USD
−88.98 M USD
36.55 M USD
41.65 M
About Stoke Therapeutics, Inc.
Sector
Industry
CEO
Ian Frederick Smith
Website
Headquarters
Bedford
Founded
2014
FIGI
BBG00JPCBPG9
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
Dark Pools Accumulating Biotech: STOKDark Pools are accumulating some biotechnology stocks for mutual funds and ETFs based on this new technology. HFTs are chasing this accumulation.
NASDAQ:STOK is now near the price when more professional traders are likely to swing trade. It has a very high Percentage of Shares Held by Instituti
STOK - long - catalyst playStoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively
Alert for Insider SellHi,
I would like to be able to create an alert based on Headlines for a stock.
When I click on the Headlines for a stock I can see news from mtnewswires like this inside TradingView:
www.tradingview.com
However, I cannot create an alert for an Insider Sell for example.
I want to be able to crea
STOK, Aroon Indicator entered an Uptrend on January 21, 2021.Over the last three days, Tickeron's A.I.dvisor has detected that STOK's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of STOK is 8.61 USD — it has increased by 7.93% in the past 24 hours. Watch Stoke Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Stoke Therapeutics, Inc. stocks are traded under the ticker STOK.
STOK stock has risen by 16.25% compared to the previous week, the month change is a 1.10% rise, over the last year Stoke Therapeutics, Inc. has showed a −25.45% decrease.
We've gathered analysts' opinions on Stoke Therapeutics, Inc. future price: according to them, STOK price has a max estimate of 47.00 USD and a min estimate of 15.00 USD. Watch STOK chart and read a more detailed Stoke Therapeutics, Inc. stock forecast: see what analysts think of Stoke Therapeutics, Inc. and suggest that you do with its stocks.
STOK reached its all-time high on Jan 20, 2021 with the price of 71.58 USD, and its all-time low was 3.35 USD and was reached on Oct 27, 2023. View more price dynamics on STOK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
STOK stock is 19.12% volatile and has beta coefficient of 1.64. Track Stoke Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Stoke Therapeutics, Inc. there?
Today Stoke Therapeutics, Inc. has the market capitalization of 465.61 M, it has increased by 20.53% over the last week.
Yes, you can track Stoke Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Stoke Therapeutics, Inc. is going to release the next earnings report on May 12, 2025. Keep track of upcoming events with our Earnings Calendar.
STOK earnings for the last quarter are −0.18 USD per share, whereas the estimation was −0.53 USD resulting in a 65.92% surprise. The estimated earnings for the next quarter are 0.11 USD per share. See more details about Stoke Therapeutics, Inc. earnings.
Stoke Therapeutics, Inc. revenue for the last quarter amounts to 22.61 M USD, despite the estimated figure of 4.28 M USD. In the next quarter, revenue is expected to reach 29.39 M USD.
STOK net income for the last quarter is −10.48 M USD, while the quarter before that showed −26.43 M USD of net income which accounts for 60.34% change. Track more Stoke Therapeutics, Inc. financial stats to get the full picture.
No, STOK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 22, 2025, the company has 128 employees. See our rating of the largest employees — is Stoke Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Stoke Therapeutics, Inc. EBITDA is −96.93 M USD, and current EBITDA margin is −265.16%. See more stats in Stoke Therapeutics, Inc. financial statements.
Like other stocks, STOK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Stoke Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Stoke Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Stoke Therapeutics, Inc. stock shows the sell signal. See more of Stoke Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.